Volume | 2,212 |
|
|||||
News | - | ||||||
Day High | 7.78 | Low High |
|||||
Day Low | 7.537 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Eliem Therapeutics Inc | ELYM | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.54 | 7.537 | 7.78 | 7.66 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
18 | 2,212 | US$ 7.58 | US$ 16,776 | - | 2.34 - 11.55 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
08:52:27 | 239 | US$ 7.537 | USD |
Eliem Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
207.9M | 27.57M | - | 0 | -35.12M | -1.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Eliem Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELYM Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.62 | 9.25 | 7.51 | 8.41 | 97,134 | -1.08 | -12.56% |
1 Month | 8.09 | 9.58 | 7.025 | 8.15 | 92,327 | -0.553 | -6.84% |
3 Months | 2.90 | 11.55 | 2.52 | 5.23 | 973,336 | 4.64 | 159.90% |
6 Months | 2.73 | 11.55 | 2.52 | 5.21 | 455,569 | 4.81 | 176.08% |
1 Year | 2.78 | 11.55 | 2.34 | 5.09 | 240,156 | 4.76 | 171.12% |
3 Years | 16.25 | 29.69 | 2.21 | 6.96 | 132,243 | -8.71 | -53.62% |
5 Years | 16.25 | 29.69 | 2.21 | 6.96 | 132,243 | -8.71 | -53.62% |
Eliem Therapeutics Description
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. |